AWM
Accredited Wealth Management Portfolio holdings
AUM
$134M
1-Year Est. Return
11.14%
This Fund
S&P 500
1 Year Est. Return
+11.14%
AUM
$134M
AUM Growth
+$10.8M
(+8.8%)
Holding
395
Top Buys
| 1 | +$11.3M | |
| 2 | +$7.49M | |
| 3 | +$7.39M | |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$6.49M |
| 5 |
FMUB
Fidelity Municipal Bond Opportunities ETF
FMUB
|
+$6.45M |
Top Sells
| 1 | +$13.7M | |
| 2 | +$7.72M | |
| 3 | +$6.93M | |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$6.65M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.3M |
Sector Composition
| 1 | Technology | 5.82% |
| 2 | Healthcare | 3.48% |
| 3 | Financials | 3% |
| 4 | Industrials | 2.49% |
| 5 | Consumer Staples | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Kyndryl
KD
$2.9B
| $91 | ﹤0.01% |
78
+75
|
|
||
377
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.45B
| $75 | ﹤0.01% |
126
+125
|
|
||
378
SoundHound AI
SOUN
$3.58B
| $65 | ﹤0.01% |
+390
|
|
||
379
Nike
NKE
$87.9B
| $40 | ﹤0.01% |
516
+376
|
|
||
380
SEALSQ Corp
LAES
$701M
| $38 | ﹤0.01% |
+630
|
|
||
381
PharmaCyte Biotech
PMCB
$7.19M
| $1 | ﹤0.01% |
+50
|
|
||
382
Bank of New York Mellon
BK
$81.2B
| – | – |
-106
|
|
||
383
Estee Lauder
EL
$35.7B
| – | – |
-75
|
|
||
384
Innoviz Technologies
INVZ
$178M
| – | – |
-1,000
|
|
||
385
Iris Energy
IREN
$12.9B
| – | – |
-500
|
|
||
|
KLG
386
DELISTED
WK Kellogg Co
KLG
| – | – |
-43
|
|
||
387
Kimberly-Clark
KMB
$34.7B
| – | – |
-32
|
|
||
388
Marvell Technology
MRVL
$65.7B
| – | – |
-300
|
|
||
389
Omnicom Group
OMC
$26.3B
| – | – |
-170
|
|
||
390
abrdn Physical Palladium Shares ETF
PALL
$1.09B
| – | – |
-150
|
|
||
391
State Street
STT
$35.1B
| – | – |
-43
|
|
||
392
Synchrony
SYF
$23.9B
| – | – |
-591
|
|
||
393
Wabtec
WAB
$44.5B
| – | – |
-47
|
|
||
394
Warner Bros
WBD
$69.9B
| – | – |
-181
|
|
||
|
OKLO
395
Oklo
OKLO
$9.89B
| – | – |
-10
|
|